UNSPSC 51381504: Mefenamic acid

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C15H15NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 367589PJ2C, chemically known as 2-diphenylaminecarboxylic acid, 2,3-dimethyl- but generally known as mefenamic acid, which bears US NIH Compound Identifier 4044. European Medicines Agency schedules Mefenamic acid in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08703MIG.

UNSPSC 51381504 Mefenamic acid is a Commodity code nominally describing a nonsteroidal anti-inflammatory drug, but recent state and local solicitation activity under this code does not align with that scope. Seminole County, Florida posted an IFB in June 2026 seeking naloxone and drug deactivation systems — pharmaceuticals and medical equipment outside the mefenamic acid product line — suggesting either a coding misclassification by the issuing body or a data tagging error in the opportunity record. State and local governments typically use this code for direct procurement of branded or generic mefenamic acid tablets and oral formulations to stock public health clinics, emergency departments, and community health programs, but the recent activity block contains no such opportunities. The solicitation does reflect core state and local pharmaceutical purchasing patterns: fixed-term contracts, quarterly delivery cycles, unit-cost pricing, and compliance requirements including drug-free workplace certification and E-Verify.

The single recent opportunity places activity in Florida, but the geographic and issuing-body signal is too thin to characterize market spread. Seminole County's IFB (IFB60459723LAS, response deadline July 26, 2023) targets naloxone and drug deactivation systems for the Seminole County Community Health Building with an initial two-year term and one-year renewal option, funded potentially through FEMA. The procurement shows no explicit set-aside designations. Because the Seminole County opportunity does not address mefenamic acid or related analgesics, this code shows little relevant recent activity in state and local procurement.